Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

SULFINPYRAZONE IMPURITY B CRS(20 MG)

SULFINPYRAZONE IMPURITY B CRS(20 MG)

NA

DISCOVER
SULFAPYRIDINE CRS (20 MG)

SULFAPYRIDINE CRS (20 MG)

144-83-2

DISCOVER
SULINDAC CRS (100 MG)

SULINDAC CRS (100 MG)

38194-50-2

DISCOVER
Sotalol HCl D6

Sotalol HCl D6

1246820-85-8

DISCOVER
SULPIRIDE CRS (100 MG)

SULPIRIDE CRS (100 MG)

15676-16-1

DISCOVER
SULPIRIDE IMPURITY A CRS (20 MG)

SULPIRIDE IMPURITY A CRS (20 MG)

26116-12-1

DISCOVER
SULPIRIDE IMPURITY B CRS (10 MG)

SULPIRIDE IMPURITY B CRS (10 MG)

33045-52-2

DISCOVER
SUXAMETHONIUM CHLORIDE CRS (1000 MG)

SUXAMETHONIUM CHLORIDE CRS (1000 MG)

6101-15-1

DISCOVER
Sodium selenite anhydrous

Sodium selenite anhydrous

10102-18-8

DISCOVER
SUXIBUZONE CRS (50 MG)

SUXIBUZONE CRS (50 MG)

27470-51-5

DISCOVER
Suxibuzone impurity B CRS, 10mg

Suxibuzone impurity B CRS, 10mg

NA

DISCOVER
Suxibuzone impurity C CRS, 10mg

Suxibuzone impurity C CRS, 10mg

NA

DISCOVER